Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Patent
1992-11-10
1995-05-30
Nucker, Christine M.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
4242231, 424815, 435237, 435238, A61K 39215, A61K 39225, C12N 706, C12N 708
Patent
active
054199077
ABSTRACT:
The present invention provides a biologically pure culture of a novel pathogenic porcine respiratory coronavirus (PRCV) and a vaccine derived therefrom effective against PRCV infection and transmissible gastroenteritis virus (TGEV) infection.
REFERENCES:
Proc. Conf. Ref. Workers Anim. Dis., Abstract No. 213, 1991, p. 38, Vaughn et al., "Characterization and Pathogenicity of Porcine Respiratory Coronavirus AR310 Isolated From a Swine Herd with Transmissible Gastroenteritis".
Proc. Int. Pig Vet. Soc. Congn., vol. 12, 1992, p. 92, Paul et al., "Characterization and Pathogenicity of a New Porcine Respiratory Coronavirus Strain AR310".
Journal of Veterinary Diagnostic Investigatigaton, vol. 5, No. 2, Apr. 1993, Colombia, Mo., pp. 184-188, Halbur et al., "Experimental Reproduction of Pneumonia in Gnotobiotic Pigs with Porcine Respiratory Coronavirus Isolate AR31".
Callebaut et al: Adv Exp Med Biol 276: 421-428, 1990.
Bernard et al; Vet Microbiol 21(1): 1-8, 1989.
Paton et al; Vet Res Commun 14(4):329-337, 1990.
Callebaut et al; J Gen Virol 69(7):1725-1730, 1988.
Van Nieuwstadt et al. Am J Vet Res 52(2):184-190, 1992.
M. B. Pensaert, "Transmissible Gastroenteritis Virus (Respiratory Variant)", in Coronaviruses, S. G. Siddell, E. D., pp. 154-165, Plenum, New York, (1992).
C. M. Sanchez, et al., in Virology, 190, 92 (1992).
R. D. Wesley, et al., J. Vet. Diagn. Invest., 3:29-32 (1991).
R. D. Wesley, et al., J. Virol., 65, 3369 (1991).
D. Rasschaert et al., J. Gen Virol., 71, 2599 (1990).
C. M. Sanchez, et al., Virology, 174, 410 (1990).
R. D. Wesley, et al., J. Vet. Diag. Invest., 2, 312 (1990).
X. Zhu, et al., Am. J. Vet. Res., 51, 232 (1990).
P. Callebaut, et al., Veterinary, 20:9-19 (1989).
H. T. Hill et al., Proc. Am. Assoc. Swine Prac., pp. 333-334 (1989).
M. B. Pensaert, et al., Agri-Practice, 10(2):17-21, Mar./Apr. (1989).
D. O'Toule et al., Res. Vet. Sci., 47, 23 (1989).
A. P. Van Nieuwstadt et al., Veterinary Record, 124, 43 (1989).
P. Callebaut, et al., J. Gen. Virol., 69, 1725 (1988).
C. Duret et al., Recueil de Medecine Veterinaire, 164, 221-226 (1988).
J. Garwes, et al., Veterinary Record, 122, 86 (1988).
H. Laude et al., Journees de law Recherche Porcine en France, 20, 89 (1988).
A. Jestin et al., Recueil de Medecine Veterinaire, 163, 567-571 (1987).
M. Pensaert, et al., Veterinary Quaterly, 8, 257 (1986).
O. P. Miniats et al., Can. J. Comp. Med., 42, 428 (1978).
H. W. Moon, J. Am. Vet. Med. Assoc., 172, 332 (1978).
L. J. Kemeny, et al., Cornell Vet., 65, 352 (1975).
Kohler, et al., Nature, 256, 495-97 (1975).
Halbur Patrick G.
Paul Prem S.
Vaughn Eric M.
Iowa State University & Research Foundation, Inc.
Krsek-Staples Julie
Nucker Christine M.
LandOfFree
Pathogenic porcine respiratory coronavirus does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pathogenic porcine respiratory coronavirus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pathogenic porcine respiratory coronavirus will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-359966